This cohort study evaluated the association between GLP-1 receptor agonist (GLP-1 RA) use and clinical outcomes — including mortality, major cardiovascular events, and systemic complications — in patients with hidradenitis suppurativa (HS).
Full text is under embargo until July 1, 2027; only the abstract is publicly available, so specific results, sample size, comparators, and follow-up duration cannot be verified or reported.
Explore related topics
